Report Categories
View AllRecent Articles
View All
DXP DXPE Q4 earnings beat masks deeper concerns as stock tanks 17 despite 119 revenue growth
What Neumora Therapeutics NMRA disclosed about crisis preparedness NMRA Neumora Therapeutics Q4 2025 Earnings EPS Miss Zero Revenue
CII BlackRock Fd lays out large cap core portfolio adjustment plans alongside latest quarterly earnings report
DXLG DXL reports steep Q1 2026 EPS miss yet shares edge slightly higher in todays trading